Summary: A novel cancer vaccine activated T cells in tumors, destroying 97% of tumors in mice, and had ‘amazing, bodywide effects,’ Stanford University researchers reported. The researchers are recruiting lymphoma patients to test the approach in a clinical trial. [This article first appeared on the website LongevityFacts.com. Author: Brady Hartman. ] Researchers at the Stanford University School of Medicine used two novel agents to … Continue reading New cancer vaccine eradicates 97% of tumors in mice